Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia

Overview of attention for article published in Journal of Hematology & Oncology, November 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 4 X users

patent: 1 patent

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 4,192 followers.

RT @iRecRepPapers: #JHematolOncol Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute…

06 Dec 2017

Reply Repost Favourite

#JHematolOncol Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia. https://t.co/pRU7Qr1zSl

06 Dec 2017

Reply Repost Favourite

RT @Hema_News: Oligoclonal Expansion of TCR Vdelta T Cells May Be a Potential Immune Biomarker for Clinical Outcome of AML https://t.co/dba…

25 Nov 2016

Reply Repost Favourite

Oligoclonal Expansion of TCR Vdelta T Cells May Be a Potential Immune Biomarker for Clinical Outcome of AML https://t.co/dbazcajGIq

25 Nov 2016

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.